What is the role of aspirin in suspected ACS in flight?

• A. Antibiotic for infection prevention
• B. Analgesic for chest pain
• C. Antiplatelet to reduce clot formation; only if not contraindicated.
• D. Antihistamine for allergic reaction

Answer: (C)

In suspected acute coronary syndrome during flight, giving aspirin is beneficial because it acts as an antiplatelet to limit clot formation, which is central to the problem in ACS. It works by irreversibly inhibiting COX-1 in platelets, which lowers thromboxane A2 and reduces platelet aggregation. Since platelets can’t make new COX-1, the antiplatelet effect lasts the life of the platelet, giving a lasting impact after a single dose. A chewable aspirin dose of about 160–325 mg is recommended promptly to maximize rapid absorption and effect while awaiting further care, provided there are no contraindications. Contraindications include aspirin allergy, active major bleeding or a high risk of bleeding, and other conditions where bleeding risk outweighs benefits. This is why aspirin is the best choice in this scenario: it directly targets the clotting process that ACS depends on, whereas antibiotics, non-antiplatelet analgesics, or antihistamines do not address the underlying pathophysiology.